Recent evidence indicates that the number of child deaths due to malaria in Africa has begun to increase, and that this is attributable to failing medicines and medicines of poor quality. Surveys indicate that due to high levels of resistance to the drugs in use, almost half of the money spent on anti-malarial medicines is being used to pay for inappropriate treatments.